{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:59:59Z","timestamp":1794628799118,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1593,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41374-018-0074-z","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T06:23:46Z","timestamp":1530253426000},"page":"1184-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water"],"prefix":"10.1016","volume":"98","author":[{"given":"Xue-Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Na","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-1507","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-018-0074-z_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/ars.2010.3749","article-title":"New insights from rodent models of fatty liver disease","volume":"15","author":"Maher","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1038\/s41374-018-0074-z_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1038\/s41374-018-0074-z_bib4","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.3390\/ijms141121833","article-title":"Rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"14","author":"Imajo","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41374-018-0074-z_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1038\/s41374-018-0074-z_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000282097","article-title":"Animal models of non-alcoholic steatohepatitis: of mice and man","volume":"28","author":"Schattenberg","year":"2010","journal-title":"Dig Dis"},{"key":"10.1038\/s41374-018-0074-z_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0074-z_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/labinvest.2013.123","article-title":"A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance","volume":"93","author":"Adkins","year":"2013","journal-title":"Lab Invest"},{"key":"10.1038\/s41374-018-0074-z_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1349-7006.2002.tb01250.x","article-title":"Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL\/6J male mice given a choline-deficient, L-amino acid-defined diet","volume":"93","author":"Denda","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1038\/s41374-018-0074-z_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ajpath.2014.01.034","article-title":"Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat\/fructose diet and sedentary lifestyle","volume":"184","author":"Dowman","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1038\/s41374-018-0074-z_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/labinvest.2017.84","article-title":"Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions","volume":"97","author":"Xu","year":"2017","journal-title":"Lab Invest"},{"key":"10.1038\/s41374-018-0074-z_bib14","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.3390\/s141018526","article-title":"Correlation of X-ray computed tomography with quantitative nuclear magnetic resonance methods for pre-clinical measurement of adipose and lean tissues in living mice","volume":"14","author":"Metzinger","year":"2014","journal-title":"Sensors (Basel)"},{"key":"10.1038\/s41374-018-0074-z_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0074-z_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0074-z_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.20288","article-title":"Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice","volume":"40","author":"Wu","year":"2004","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0074-z_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yexmp.2010.05.005","article-title":"Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma","volume":"89","author":"Lingala","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/s41374-018-0074-z_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jhep.2010.12.043","article-title":"Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations","volume":"55","author":"Chen","year":"2011","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1038\/s41374-018-0074-z_bib21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1038\/s41374-018-0074-z_bib22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1038\/s41374-018-0074-z_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.29514","article-title":"The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial","volume":"67","author":"Loomba","year":"2017","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0074-z_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0074-z_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0074-z_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tem.2013.01.003","article-title":"Novel insights into ChREBP regulation and function","volume":"24","author":"Filhoulaud","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/s41374-018-0074-z_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tem.2011.07.002","article-title":"Hepatic FXR: key regulator of whole-body energy metabolism","volume":"22","author":"Teodoro","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/s41374-018-0074-z_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARalpha expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"10.1038\/s41374-018-0074-z_bib31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1038\/s41374-018-0074-z_bib32","doi-asserted-by":"crossref","first-page":"21873","DOI":"10.3390\/ijms141121873","article-title":"Hepatic adverse effects of fructose consumption independent of overweight\/obesity","volume":"14","author":"Schultz","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41374-018-0074-z_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2015.05.031","article-title":"PPARalpha\/gamma agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats","volume":"75","author":"Zhang","year":"2015","journal-title":"Cytokine"},{"key":"10.1038\/s41374-018-0074-z_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1038\/s41374-018-0074-z_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0074-z_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0074-z_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","article-title":"The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/s41374-018-0074-z_bib38","doi-asserted-by":"crossref","first-page":"e27909","DOI":"10.5812\/hepatmon.15(5)2015.27909","article-title":"Saturated fatty acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic fatty liver disease by toll-like receptor 4-mediated innate immune response","volume":"15","author":"Zhang","year":"2015","journal-title":"Hepat Mon"},{"key":"10.1038\/s41374-018-0074-z_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejphar.2011.03.033","article-title":"A novel agonist of PPAR-gamma based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance","volume":"659","author":"Zheng","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/s41374-018-0074-z_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12358-8","article-title":"Exercise training enhances in vivo clearance of endotoxin and attenuates inflammatory responses by potentiating Kupffer cell phagocytosis","volume":"7","author":"Komine","year":"2017","journal-title":"Sci Rep"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0074-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722010133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722010133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:34:05Z","timestamp":1758396845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722010133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0023683722010133"],"URL":"https:\/\/doi.org\/10.1038\/s41374-018-0074-z","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-018-0074-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}